Ankit Sakhuja

Ankit Sakhuja

Auto-generated profile, based on publicly available information

Ankit Sakhuja

The Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
PJPushkala Jayaraman
Pushkala Jayaraman
JDJacob Desman
Jacob Desman
MSMoein Sabounchi
Moein Sabounchi
Girish N. NadkarniGirish N. Nadkarni
Girish N. Nadkarni
ASAnkit Sakhuja
Ankit Sakhuja
Reinforcement Learning (RL) is a machine learning paradigm that enhances clinical decision-making for healthcare professionals by addressing uncertainties and optimizing sequential treatment strategies. RL leverages patient-data to create personalized treatment plans, improving outcomes and resource efficiency. This review introduces RL to a clinical audience, exploring core concepts, potential applications, and challenges in integrating RL into clinical practice, offering insights into efficient, personalized, and effective patient care.

23 February 2026 in Nature Medicine
Verified
Journal Article
Open access
PDF file
ARAshwin Ramaswamy
Ashwin Ramaswamy
ATAlvira Tyagi
Alvira Tyagi
HHHannah Hugo
Hannah Hugo
JJJoy Jiang
Joy Jiang
PJPushkala Jayaraman
Pushkala Jayaraman
Girish N. NadkarniGirish N. Nadkarni
Girish N. Nadkarni
ChatGPT Health was launched in January 2026 as OpenAI’s consumer health tool and has reached millions of users. Here we conducted a structured stress test of triage recommendations using 60 clinician-authored vignettes across 21 clinical domains under 16 factorial conditions, yielding 960 total responses. Performance followed an inverted U-shaped pattern, with the most dangerous failures concentrated at clinical extremes—nonurgent presentations (35%) and emergency conditions (48%). Among gold-standard emergencies, the system undertriaged 52% of cases, directing patients with diabetic ketoacidosis or impending respiratory failure to 24–48 h evaluation rather than the emergency department, while correctly triaging classical emergencies such as stroke and anaphylaxis. When family or friends minimized symptoms, indicating anchoring bias, triage recommendations shifted significantly in edge cases (odds ratio = 11.7, 95% confidence interval = 3.7–36.6), with the majority of shifts toward less urgent care. Crisis-intervention messages activated unpredictably across suicidal ideation presentations, occurring more frequently when patients described no specific method than when they did. Patient race, sex and barriers to care did not show significant effects, although confidence intervals did not exclude clinically meaningful differences. These findings reveal missed high-risk emergencies and inconsistent activation of crisis safeguards, raising safety concerns that warrant prospective validation before consumer-scale deployment of artificial intelligence triage systems.

10 May 2024 in Critical Care
Verified
Journal Article
Open access
PDF file
KTKullaya Takkavatakarn
Kullaya Takkavatakarn
WOWonsuk Oh
Wonsuk Oh
LCLili Chan
Lili Chan
IHIra Hofer
Ira Hofer
KSKhaled Shawwa
Khaled Shawwa
ASAnkit Sakhuja
Ankit Sakhuja
Background: Current classification for acute kidney injury (AKI) in critically ill patients with sepsis relies only on its severity-measured by maximum creatinine which overlooks inherent complexities and longitudinal evaluation of this heterogenous syndrome. The role of classification of AKI based on early creatinine trajectories is unclear. Methods: This retrospective study identified patients with Sepsis-3 who developed AKI within 48-h of intensive care unit admission using Medical Information Mart for Intensive Care-IV database. We used latent class mixed modelling to identify early creatinine trajectory-based classes of AKI in critically ill patients with sepsis. Our primary outcome was development of acute kidney disease (AKD). Secondary outcomes were composite of AKD or all-cause in-hospital mortality by day 7, and AKD or all-cause in-hospital mortality by hospital discharge. We used multivariable regression to assess impact of creatinine trajectory-based classification on outcomes, and eICU database for external validation. Results: Among 4197 patients with AKI in critically ill patients with sepsis, we identified eight creatinine trajectory-based classes with distinct characteristics. Compared to the class with transient AKI, the class that showed severe AKI with mild improvement but persistence had highest adjusted risks for developing AKD (OR 5.16; 95% CI 2.87–9.24) and composite 7-day outcome (HR 4.51; 95% CI 2.69–7.56). The class that demonstrated late mild AKI with persistence and worsening had highest risks for developing composite hospital discharge outcome (HR 2.04; 95% CI 1.41–2.94). These associations were similar on external validation. Conclusions: These 8 classes of AKI in critically ill patients with sepsis, stratified by early creatinine trajectories, were good predictors for key outcomes in patients with AKI in critically ill patients with sepsis independent of their AKI staging.

26 May 2025 in Critical Care
Verified
Journal Article
Open access
PDF file
WOWonsuk Oh
Wonsuk Oh
MVMarinela Veshtaj
Marinela Veshtaj
ASAshwin Sawant
Ashwin Sawant
PAPulkit Agrawal
Pulkit Agrawal
HGHernando Gomez
Hernando Gomez
ASAnkit Sakhuja
Ankit Sakhuja
Background: Major Adverse Kidney Events within 30 days (MAKE30) is an important patient-centered outcome for assessing the impact of acute kidney injury (AKI). Existing prediction models for MAKE30 are static and overlook dynamic changes in clinical status. We introduce ORAKLE, a novel deep-learning model that utilizes evolving time-series data to predict MAKE30, enabling personalized, patient-centered approaches to AKI management and outcome improvement. Methods: We conducted a retrospective study using three publicly available critical care databases: MIMIC-IV as the development cohort, and SiCdb and eICU-CRD as external validation cohorts. Patients with sepsis-3 criteria who developed AKI within 48 h of intensive care unit admission were identified. Our primary outcome was MAKE30, defined as a composite of death, new dialysis or persistent kidney dysfunction within 30 days of ICU admission. We developed ORAKLE using Dynamic DeepHit framework for time-series survival analysis and its performance against Cox and XGBoost models. We further assessed model calibration using Brier score. Results: We analyzed 16,671 patients from MIMIC-IV, 2665 from SICdb, and 11,447 from eICU-CRD. ORAKLE outperformed the XGBoost and Cox models in predicting MAKE30, achieving AUROCs of 0.84 (95% CI: 0.83–0.86) vs. 0.81 (95% CI: 0.79–0.83) vs. 0.80 (95% CI: 0.78–0.82) in MIMIC-IV internal test set, 0.83 (95% CI: 0.81–0.85) vs. 0.80 (95% CI: 0.78–0.83) vs. 0.79 (95% CI: 0.77–0.81) in SICdb, and 0.85 (95% CI: 0.84–0.85) vs. 0.83 (95% CI: 0.83–0.84) vs. 0.81 (95% CI: 0.80–0.82) in eICU-CRD. The AUPRC values for ORAKLE were also significantly better than that of XGBoost and Cox models. The Brier score for ORAKLE was 0.21 across the internal test set, SICdb, and eICU-CRD, suggesting good calibration. Conclusions: ORAKLE is a robust deep-learning model for predicting MAKE30 in critically ill patients with AKI that utilizes evolving time series data. By incorporating dynamically changing time series features, the model captures the evolving nature of kidney injury, treatment effects, and patient trajectories more accurately. This innovation facilitates tailored risk assessments and identifies varying treatment responses, laying the groundwork for more personalized and effective management approaches.

22 June 2023 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JMJ. Hunter Mehaffey
J. Hunter Mehaffey
JHJ.W. Awori Hayanga
J.W. Awori Hayanga
MKMohammad Kawsara
Mohammad Kawsara
ASAnkit Sakhuja
Ankit Sakhuja
CMChristopher Mascio
Christopher Mascio
VBVinay Badhwar
Vinay Badhwar

28 July 2024 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
HKHannah D. Kittrell
Hannah D. Kittrell
ASAhmed Shaikh
Ahmed Shaikh
PAPeter A. Adintori
Peter A. Adintori
PMPaul McCarthy
Paul McCarthy
RKRoopa Kohli‐Seth
Roopa Kohli‐Seth
ASAnkit Sakhuja
Ankit Sakhuja